Literature DB >> 6408544

Hysterectomy in the United States.

C L Easterday, D A Grimes, J A Riggs.   

Abstract

Hysterectomy is the most frequently performed major operation in the United States--and one of the most controversial. Although there are large regional differences in hysterectomy rates, the nationwide rate declined between 1975 and 1980. Leiomyomas, dysfunctional uterine bleeding, and pelvic relaxation are among the most frequent indications for hysterectomy. One fourth to one half of all women who undergo hysterectomy develop some morbidity, with fever and hemorrhage the most common types. Late sequelae may include the residual ovary syndrome, depression, and an increased risk of cardiovascular disease. The mortality rate appears to be about one death per 1000 operations. Neither prevention of cancer nor contraceptive sterilization appears to justify elective hysterectomy in asymptomatic women. Hysterectomy will continue to be an important component of women's health care. Ongoing peer review activities, improvements in surgical technique, and continued research should help ensure that each hysterectomy performed is both appropriate and safe.

Entities:  

Mesh:

Year:  1983        PMID: 6408544

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  An American health dilemma: a history of blacks in the health system.

Authors:  W M Byrd; L A Clayton
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

2.  Hysterectomy and autonomy.

Authors:  E W Bernal
Journal:  Theor Med       Date:  1988-02

3.  Hysterectomy: variations in rates across small areas and across physicians' practices.

Authors:  N P Roos
Journal:  Am J Public Health       Date:  1984-04       Impact factor: 9.308

4.  Unnecessary Hysterectomy due to Menorrhagia and Disorders of Hemostasis: An Example of Overuse and Excessive Demand for Medical Services.

Authors:  Svetlana M Djukic; Danijela Lekovic; Nikola Jovic; Mirjana Varjacic
Journal:  Front Pharmacol       Date:  2016-12-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.